BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06103864-completion@plaintrial.com
DTSTAMP:20261027T152840Z
DTSTART;VALUE=DATE:20300930
SUMMARY:A Phase III Study of Dato-DXd With or Without Durvalumab Compared W
 ith Investigator's Choice of Chemotherapy in Combination With Pembrolizuma
 b in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastat
 ic Triple-negative Breast Cancer — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06103864
URL:https://plaintrial.com/trial/NCT06103864
END:VEVENT
END:VCALENDAR